Drug Shortage Report for MIDAZOLAM INJECTION USP
Report ID | 139380 |
Drug Identification Number | 02498022 |
Brand name | MIDAZOLAM INJECTION USP |
Common or Proper name | Midazolam Injection USP |
Company Name | STERINOVA INC. |
Market Status | MARKETED |
Active Ingredient(s) | MIDAZOLAM |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | Box of 30 x 100 mL |
ATC code | N05CD |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2021-05-31 |
Actual start date | |
Estimated end date | |
Actual end date | 2021-06-10 |
Shortage status | Resolved |
Updated date | 2021-06-11 |
Company comments | Resolved |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3005 AVENUE JOSE-MARIA ROSELL SAINT-HYACINTHE, QUEBEC CANADA J2S 0J9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-06-11 | English | Compare |
v8 | 2021-06-10 | French | Compare |
v7 | 2021-06-10 | English | Compare |
v6 | 2021-06-10 | English | Compare |
v5 | 2021-06-10 | English | Compare |
v4 | 2021-06-10 | English | Compare |
v3 | 2021-06-01 | English | Compare |
v2 | 2021-05-14 | French | Compare |
v1 | 2021-05-14 | English | Compare |
Showing 1 to 9 of 9